Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance.
Sci Adv. 2023 Feb 10;9(6):eade9238. doi: 10.1126/sciadv.ade9238. Epub 2023 Feb 8.
Sci Adv. 2023.
PMID: 36753540
Free PMC article.
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma.
Pomella S, Danielli SG, Alaggio R, Breunis WB, Hamed E, Selfe J, Wachtel M, Walters ZS, Schäfer BW, Rota R, Shipley JM, Hettmer S.
Pomella S, et al. Among authors: danielli sg.
Cancers (Basel). 2023 May 18;15(10):2823. doi: 10.3390/cancers15102823.
Cancers (Basel). 2023.
PMID: 37345159
Free PMC article.
Review.
Item in Clipboard
PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution.
Asante Y, Benischke K, Osman I, Ngo QA, Wurth J, Laubscher D, Kim H, Udhayakumar B, Khan MIH, Chin DH, Porch J, Chakraborty M, Sallari R, Delattre O, Zaidi S, Morice S, Surdez D, Danielli SG, Schäfer BW, Gryder BE, Wachtel M.
Asante Y, et al. Among authors: danielli sg.
Nat Commun. 2023 Dec 15;14(1):8361. doi: 10.1038/s41467-023-43780-4.
Nat Commun. 2023.
PMID: 38102136
Free PMC article.
Item in Clipboard
Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study.
Ruhen O, Lak NSM, Stutterheim J, Danielli SG, Chicard M, Iddir Y, Saint-Charles A, Di Paolo V, Tombolan L, Gatz SA, Aladowicz E, Proszek P, Jamal S, Stankunaite R, Hughes D, Carter P, Izquierdo E, Wasti A, Chisholm JC, George SL, Pace E, Chesler L, Aerts I, Pierron G, Zaidi S, Delattre O, Surdez D, Kelsey A, Hubank M, Bonvini P, Bisogno G, Di Giannatale A, Schleiermacher G, Schäfer BW, Tytgat GAM, Shipley J.
Ruhen O, et al. Among authors: danielli sg.
JCO Precis Oncol. 2022 Oct;6:e2100534. doi: 10.1200/PO.21.00534.
JCO Precis Oncol. 2022.
PMID: 36265118
Free PMC article.
Item in Clipboard
Evaluation of the role of AXL in fusion-positive pediatric rhabdomyosarcoma identifies the small-molecule inhibitor bemcentinib (BGB324) as potent chemosensitizer.
Danielli SG, Wurth J, Morice S, Kisele S, Surdez D, Delattre O, Bode PK, Wachtel M, Schafer BW.
Danielli SG, et al.
Mol Cancer Ther. 2024 Mar 13. doi: 10.1158/1535-7163.MCT-23-0285. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38471796
Item in Clipboard
Cite
Cite